Quantcast
Last updated on April 23, 2014 at 16:13 EDT

Latest Glycosides Stories

2009-06-29 08:28:55

High ozone conditions cause a 30% decrease in yield and an increase in the concentration of a group of toxic compounds within oilseed rape plants. Combined with the results of previous studies which have shown a decrease in oil, protein and carbohydrate content of oilseed rape seeds in high ozone, these results (to be presented at the Society for Experimental Biology Annual Main Meeting in Glasgow on 29th June 2009) could signal a significant income loss for farmers and an indirect effect on...

2009-05-28 16:01:00

HORSHAM, Pa., May 28 /PRNewswire/ -- Centocor Ortho Biotech Products, L.P. today announced that data related to several compounds will be presented at the 45th American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Fla., from May 29 to June 2, 2009. The studies were sponsored by Centocor Ortho Biotech Products, L.P. or its research partner, Ortho Biotech Oncology Research and Development, a unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. "We...

2009-05-21 15:05:00

PALO ALTO, Calif., May 21 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced today that the results from the randomized clinical study of canfosfamide (TELCYTA(R), TLK286) in combination with pegylated liposomal doxorubicin (PLD) vs. PLD will be presented at the 45th annual meeting of the American Society of Clinical Oncology (ASCO) which will be held from May 29 to June 2 in Orlando, FL. Details of the presentation are as follows: -- Abstract #5552 - General Poster...

2009-05-19 10:00:00

Updated Safety data presented at BIO International Convention in Atlanta ATLANTA, May 19 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) released updated safety data today from its pixantrone phase III 301 EXTEND trial demonstrating the effectiveness of pixantrone in patients with relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) for whom anthracycline-related drugs are typically not to be used due to the increased risk of cardiac failure. As noted...

2009-05-13 23:00:00

FLORHAM PARK, N.J., May 14 /PRNewswire/ -- In the keynote speech given in Shanghai at Stevia World 2009 (May 14-15), the annual conference for producers and food and beverage companies, Dorn Wenninger, Corporate VP Supply Chain with PureCircle, the major Reb A producer, announced today that Reb A is now fully competitive with sugar for global brands with global volume. At the conference, Wenninger shared key success factors in his presentation entitled, "Key Success of Reb A to multinational...

2009-03-31 11:05:59

Caltech researcher helps develop technique that homes in on aggressive, difficult-to-treat HER2+ breast cancer cellsCombining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, says a team of researchers from the California Institute of Technology (Caltech), the Israel Institute of Technology (Technion) and the Cedars-Sinai...

2009-03-30 10:49:00

FLORHAM PARK, N.J., March 30 /PRNewswire/ -- Following the launch of several high profile consumer product brands containing PureVia(TM)Reb A, PureCircle, the world's leading producer of Reb A, has been invited to share current insights on its rapidly developing global stevia supply chain at Stevia World 2009 on May 14-15, in Shanghai. PureCircle produces and markets a range of natural sweeteners internationally and is involved in the sourcing of dry stevia leaves, extraction, refining of...

2009-03-18 06:00:00

PRINCETON, N.J., March 18 /PRNewswire/ -- Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced that it completed enrollment in its pivotal Phase III study of nonpegylated liposomal doxorubicin (Myocet(TM)) in metastatic HER-2-overexpressing breast cancer. This is a pivotal Phase III trial of Sopherion's lead product in combination with the current standard of care, paclitaxel (Taxol) and trastuzumab...

2009-03-03 08:59:47

Here's another reason to eat your broccoli: UCLA researchers report that a naturally occurring compound found in broccoli and other cruciferous vegetables may help protect against respiratory inflammation that causes conditions like asthma, allergic rhinitis and chronic obstructive pulmonary disease.Published in the March edition of the journal Clinical Immunology, the research shows that sulforaphane, a chemical in broccoli, triggers an increase of antioxidant enzymes in the human airway...

2009-02-25 05:30:00

VANCOUVER, British Columbia, Feb. 25 /PRNewswire-FirstCall/ -- GLG Life Tech Corporation (TSX: GLG) ("GLG" or the "Company"), the vertically integrated leader in the agricultural and industrial development of rebiana including R&D, high quality stevia plant growth, production and marketing, announces that the Company's patent application for its newly engineered and environmentally friendly waste water treatment system has been accepted by the State Intellectual Property Bureau of the...


Latest Glycosides Reference Libraries

45_20138aaa34c0aef5a2af87b137102229
2009-04-23 11:07:34

Bittercress (Barbarea vulgaris), also commonly known as Herb Barbara, Rocketcress, Yellow Rocketcress, Winter Rocket, and Wound Rocket, is a European biennial herb. This plant displays a rosette of shiny, dark green leaves at the base and additional pinnately divided leaves on the stem. In the spring, yellow flowers originate in tightly packed terminal groups just above the foliage. Bittercress grows wildly as a weed in many parts of North America. The flowers can be in bloom May...

More Articles (1 articles) »